Methods for Studying Signal-Dependent Regulation of Translation Factor Activity

Methods in Enzymology

Volumn 431, Issue , 2007, Pages 113-142

  Wang, Xuemin ^a   Proud, Christopher G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; INITIATION FACTOR; INITIATION FACTOR 4E BINDING PROTEIN 1; INITIATION FACTOR 4F; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN; UO 126; WORTMANNIN; ENZYME INHIBITOR; PROTEIN KINASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; CONTROLLED STUDY; CYTOLYSIS; IMMUNOPRECIPITATION; ISOELECTRIC FOCUSING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; TRANSLATION REGULATION; WESTERN BLOTTING; ANIMAL; BIOLOGICAL MODEL; CELL CULTURE; DIAGNOSIS, MEASUREMENT AND ANALYSIS; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; METHODOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

EUKARYOTA; MAMMALIA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELLS, CULTURED; ENZYME INHIBITORS; EUKARYOTIC INITIATION FACTORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HUMANS; IMMUNOPRECIPITATION; ISOELECTRIC FOCUSING; LABORATORY TECHNIQUES AND PROCEDURES; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PROTEIN KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 38449110890     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(07)31007-0     Document Type: Review

References (76)

1. Abraham R.T. PI 3-kinase related kinases: "Big" players in stress-induced signaling pathways. DNA Repair (Amst.) 3 (2004) 883-887
2. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., and Saltiel A.R. PD-098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J. Biol. Chem. 270 (1995) 27489-27494
3. Arcaro A., and Wymann M.P. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: The role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem. J. 296 (1993) 297-301
4. Avruch J., Belham C., Weng Q., Hara K., and Yonezawa K. The p70 S6 kinase integrates nutrient and growth signals to control translational capacity. Prog. Mol. Subcell. Biol. 26 (2001) 115-154
5. Bain J., McLauchlan H., Elliott M., and Cohen P. The specificities of protein kinase inhibitors: An update. Biochem. J. 371 (2003) 199-204
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 77 (1976) 248-254
7. Brunn G.J., Williams J., Sabers C., Weiderrecht G., Lawrence J.C., and Abraham R.T. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 15 (1996) 5256-5267
8. Buxade M., Parra J.L., Rousseau S., Shpiro N., Marquez R., Morrice N., Bain J., Espel E., and Proud C.G. The Mnks are novel components in the control of TNFalpha biosynthesis and phosphorylate and regulate hnRNP A1. Immunity 23 (2005) 177-189
9. Cai S.L., Tee A.R., Short J.D., Bergeron J.M., Kim J., Shen J., Guo R., Johnson C.L., Kiguchi K., and Walker C.L. Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J. Cell Biol. 173 (2006) 279-289
10. Cheatham B., Vlahos C.J., Cheatham L., Wang L., Blenis J., and Kahn C.R. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14 (1994) 4902-4911
11. Chen R.H., and Blenis J. Identification of Xenopus S6 protein kinase homologs (pp90rsk) in somatic cells: Phosphorylation and activation during initiation of cell proliferation. Mol. Cell. Biol. 10 (1990) 3204-3215
12. Cohen P., and Frame S. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2 (2001) 769-776
13. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., and Lee J.C. SB-203580 is a specific inhibitor of a MAP kinase homolog which is activated by cellular stresses and interleukin-1. FEBS Lett. 364 (1995) 229-233
14. Davies S.P., Reddy H., Caivano M., and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351 (2000) 95-105
15. Dokladda K., Green K.A., Pan D.A., and Hardie D.G. PD98059 and U0126 activate AMP-activated protein kinase by increasing the cellular AMP:ATP ratio and not via inhibition of the MAP kinase pathway. FEBS Lett. 579 (2005) 236-240
16. Dudley D.T., Pang L., Decker S.J., Bridges A.J., and Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92 (1995) 7686-7689
17. Favata M.F., Horiuchi K.Y., Manos E., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273 (1998) 18623-18632
18. Harrington L.S., Findlay G.M., Tolkacheva T., Gray A., Wigfield S., Rebholz H., Barnett J., Leslie N.R., Cheng S., Shepherd P.R., Gout I., Downes C.P., et al. The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J. Cell Biol. 166 (2004) 213-223
19. Herbert T.P., Kilhams G.R., Batty I.H., and Proud C.G. Distinct signaling pathways mediate insulin and phorbol ester-stimulated eIF4F assembly and protein synthesis in HEK 293 cells. J. Biol. Chem. 275 (2000) 11249-11256
20. Herbert T.P., and Proud C.G. Regulation of translation elongation and the cotranslational protein targeting pathway. In: Mathews M.B., Sonenberg N., and Hershey J.W.B. (Eds). "Translational Control in Biology and Medicine" (2006), Cold Spring Harbor Laboratory Press, Cold Spring, NY 601-624
21. Hitti E., Iakovleva T., Brook M., Deppenmeier S., Gruber A.D., Radzioch D., Clark A.R., Blackshear P.J., Kotlyarov A., and Gaestel M. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol. Cell Biol. 26 (2006) 2399-2407
22. Holz M.K., and Blenis J. Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase. J. Biol. Chem. 280 (2005) 26089-26093
23. Inoki K., Ouyang H., Zhu T., Lindvall C., Wang Y., Zhang X., Yang Q., Bennett C., Harada Y., Stankunas K., Wang C.Y., He X., et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126 (2006) 955-968
24. Jacinto E., Facchinetti V., Liu D., Soto N., Wei S., Jung S.Y., Huang Q., Qin J., and Su B. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127 (2006) 125-137
25. Kamakura S., Moriguchi T., and Nishida E. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. J. Biol. Chem. 274 (1999) 26563-26571
26. Kang Y.J., Seit-Nebi A., Davis R.J., and Han J. Multiple activation mechanisms of p38alpha mitogen-activated protein kinase. J. Biol. Chem. 281 (2006) 26225-26234
27. Knauf U., Tschopp C., and Gram H. Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2. Mol. Cell. Biol. 21 (2001) 5500-5511
28. Kotlyarov A., Yannoni Y., Fritz S., Laass K., Telliez J.B., Pitman D., Lin L.L., and Gaestel M. Distinct cellular functions of MK2. Mol. Cell Biol. 22 (2002) 4827-4835
29. Lali F.V., Hunt A.E., Turner S.J., and Foxwell B.M. The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase. J. Biol. Chem. 275 (2000) 7395-7402
30. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., McNulty D., Blumenthal M.J., Heys J.R., Landvatter S.W., Strickler J.E., McLaughlin M.M., et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372 (1994) 739-746
31. Lindmo K., and Stenmark H. Regulation of membrane traffic by phosphoinositide 3-kinases. J. Cell Sci. 119 (2006) 605-614
32. Long X., Lin Y., Ortiz-Vega S., Yonezawa K., and Avruch J. Rheb binds and regulates the mTOR kinase. Curr. Biol. 15 (2005) 702-713
33. Mader S., Lee H., Pause A., and Sonenberg N. The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4gamma and the translational repressors 4E-binding proteins. Mol. Cell. Biol. 15 (1995) 4990-4997
34. Manke I.A., Nguyen A., Lim D., Stewart M.Q., Elia A.E., and Yaffe M.B. MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol. Cell 17 (2005) 37-48
35. Manning B.D., and Cantley L.C. United at last: The tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signaling. Biochem. Soc. Trans. 31 (2003) 573-578
36. Manning B.D., Tee A.R., Logsdon M.N., Blenis J., and Cantley L.C. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell 10 (2002) 151-162
37. Moule S.K., Edgell N.J., Welsh G.I., Diggle T.A., Foulstone E.J., Heesom K.J., Proud C.G., and Denton R.M. Multiple signaling pathways involved in the stimulation of fatty acid and glycogen synthesis by insulin in rat epididymal fat pads. Biochem. J. 311 (1995) 595-601
38. Nishimoto S., and Nishida E. MAPK signaling: ERK5 versus ERK1/2. EMBO Rep. 7 (2006) 782-786
39. O'Loghlen A., Gonzalez V.M., Pineiro D., Perez-Morgado M.I., Salinas M., and Martin M.E. Identification and molecular characterization of Mnk1b, a splice variant of human MAP kinase-interacting kinase Mnk1. Exp. Cell Res. 299 (2004) 343-355
40. Parra J.L., Buxade M., and Proud C.G. Features of the catalytic domains and C termini of the MAPK signal-integrating kinases Mnk1 and Mnk2 determine their differing activities and regulatory properties. J. Biol. Chem. 280 (2005) 37623-37633
41. Patti M.-E., Brambilla E., Luzi L., Landaker E.J., and Kahn C.R. Bidirectional modulation of insulin action by amino acids. J. Clin. Invest. 101 (1998) 1519-1529
42. Pende M., Um S.H., Mieulet V., Sticker M., Goss V.L., Mestan J., Mueller M., Fumagalli S., Kozma S.C., and Thomas G. S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol. Cell Biol. 24 (2004) 3112-3124
43. Poteet-Smith C.E., Smith J.A., Lannigan D.A., Freed T.A., and Sturgill T.W. Generation of constitutively active p90 ribosomal S6 kinase in vivo. Implications for the mitogen-activated protein kinase-activated protein kinase family. J. Biol. Chem. 274 (1999) 22135-22138
44. Rolfe M., McLeod L.E., Pratt P.F., and Proud C.G. Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2). Biochem. J. 388 (2005) 973-984
45. Roux P.P., and Blenis J. ERK and p38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68 (2004) 320-344
46. Roux P.P., Shahbazian D., Vu H., Holz M.K., Cohen M.S., Taunton J., Sonenberg N., and Blenis J. RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation. J. Biol. Chem. 282 (2007) 14056-14064
47. Sabers C.J., Martin M.M., Brunn G.J., Williams J.M., Dumont F.T., Wiederrecht G., and Abraham R.T. J. Biol. Chem. 270 (1995) 815-822
48. Sapkota G.P., Cummings L., Newell F.S., Armstrong C., Bain J., Frodin M., Grauert M., Hoffmann M., Schnapp G., Steegmaier M., Cohen P., and Alessi D.R. BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo. Biochem. J. 401 (2007) 29-38
49. Sarbassov D.D., Guertin D.A., Ali S.M., and Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 (2005) 1098-1101
50. Sarbassov D.D., Ali S.M., Sengupta S., Sheen J.H., Hsu P.P., Bagley A.F., Markhard A.L., and Sabatini D.M. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22 (2006) 159-168
51. Scheper G.C., Morrice N.A., Kleijn M., and Proud C.G. The MAP kinase signal-integrating kinase Mnk2 is an eIF4E kinase with high basal activity in mammalian cells. Mol. Cell. Biol. 21 (2001) 743-754
52. Scheper G.C., Parra J.-L., Wilson M.L., van Kollenburg B., Vertegaal A.C.O., Han Z.-G., and Proud C.G. The N and C termini of the splice variants of the human mitogen-activated protein kinase-interacting kinase Mnk2 determine activity and localization. Mol. Cell. Biol. 23 (2003) 5692-5705
53. Shahbazian D., Roux P.P., Mieulet V., Cohen M.S., Raught B., Taunton J., Hershey J.W., Blenis J., Pende M., and Sonenberg N. The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J. 25 (2006) 2781-2791
54. Smith E.M., Finn S.G., Tee A.R., Browne G.J., and Proud C.G. The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses. J. Biol. Chem. 280 (2005) 18717-18727
55. Stern B.D., Wilson M., and Jagus R. Use of nonreducing SDS-PAGE for monitoring renaturation of recombinant protein synthesis initiation factor, eIF-4 alpha. Protein Expr. Purif. 4 (1993) 320-327
56. Stokoe D., Engel K., Campbell D.G., Cohen P., and Gaestel M. Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins. FEBS Lett. 313 (1992) 307-313
57. Sutherland C., Alterio J., Campbell D.G., Le Bourdelles B., Mallet J., Haavik J., and Cohen P. Phosphorylation and activation of human tyrosine hydroxylase in vitro by mitogen-activated protein (MAP) kinase and MAP-kinase-activated kinases 1 and 2. Eur. J. Biochem. 217 (1993) 715-722
58. Sutherland C., and Cohen P. The alpha-isoform of glycogen synthase kinase-3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase-activated protein kinase-1 in vitro. FEBS Lett. 338 (1994) 37-42
59. Tschopp C., Knauf U., Brauchle M., Zurini M., Ramage P., Glueck D., New L., Han J., and Gram H. Phosphorylation of eIF-4E on Ser 209 in response to mitogenic and inflammatory stimuli is faithfully detected by specific antibodies. Mol. Cell Biol. Res. Commun. 3 (2000) 205-211
60. Ueda T., Watanabe-Fukunaga R., Fukuyama H., Nagata S., and Fukunaga R. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol. Cell Biol. 24 (2004) 6539-6549
61. Um S.H., Frigerio F., Watanabe M., Picard F., Joaquin M., Sticker M., Fumagalli S., Allegrini P.R., Kozma S.C., Auwerx J., and Thomas G. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431 (2004) 200-205
62. Vlahos C.J., Matter W.F., Hui K.Y., and Brown R.F. J. Biol. Chem. 269 (1994) 5241-5248
63. Wang L., and Proud C.G. Ras/Erk signaling is essential for activation of protein synthesis by Gq protein-coupled receptor agonists in adult cardiomyocytes. Circ. Res. 91 (2002) 821-829
64. Wang L., and Proud C.G. Regulation of the phosphorylation of elongation factor 2 by MEK-dependent signaling in adult rat cardiomyocytes. FEBS Lett. 531 (2002) 285-289
65. Wang X., Beugnet A., Murakami M., Yamanaka S., and Proud C.G. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins. Mol. Cell Biol. 25 (2005) 2558-2572
66. Wang X., Flynn A., Waskiewicz A.J., Webb B.L.J., Vries R.G., Baines I.A., Cooper J., and Proud C.G. The phosphorylation of eukaryotic initiation factor eIF4E in response to phorbol esters, cell stresses, and cytokines is mediated by distinct MAP kinase pathways. J. Biol. Chem. 273 (1998) 9373-9377
67. Wang X., Li W., Parra J.-L., Beugnet A., and Proud C.G. The C-terminus of initiation factor 4E-binding protein 1 contains multiple regulatory features that influence its function and phosphorylation. Mol. Cell. Biol. 23 (2003) 1546-1557
68. RSK1 and p70 S6 kinase. EMBO J. 20 (2001) 4370-4379
69. Wang X., and Proud C.G. The mTOR pathway in the control of protein synthesis. Physiology (Beth.) 21 (2006) 362-369
70. Waskiewicz A.J., Flynn A., Proud C.G., and Cooper J.A. Mitogen-activated kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16 (1997) 1909-1920
71. Waskiewicz A.J., Johnson J.C., Penn B., Mahalingam M., Kimball S.R., and Cooper J.A. Phosphorylation of the cap-binding protein eukaryotic translation factor 4E by protein kinase Mnk1 in vivo. Mol. Cell. Biol. 19 (1999) 1871-1880
72. Welsh G.I., Miller C.M., Loughlin A.J., Price N.T., and Proud C.G. Regulation of eukaryotic initiation factor eIF2B: Glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett. 421 (1998) 125-130
73. Weng Q.-P., Kozlowski M., Belham C., Zhang A., Comb M.J., and Avruch J. Regulation of the p70 S6 kinase by phosphorylation in vivo: Analysis using site-specific anti-phosphopeptide antibodies. J. Biol. Chem. 273 (1998) 16621-16629
74. Williams D.D., Loughlin A.J., and Proud C.G. Characterization of the initiation factor eIF2B complex from mammalian cells as a GDP-dissociation stimulator protein. J. Biol. Chem. 276 (2001) 24697-24703
75. Wullschleger S., Loewith R., and Hall M.N. TOR signaling in growth and metabolism. Cell 124 (2006) 471-484
76. Zhang H., Shi X., Hampong M., Blanis L., and Pelech S. Stress-induced inhibition of ERK1 and ERK2 by direct interaction with p38 MAP kinase. J. Biol. Chem. 276 (2001) 6905-6908